Dlk1 is a novel adrenocortical stem/progenitor cell marker that predicts malignancy in adrenocortical carcinoma

被引：0

作者：

Mariniello, Katia ^{[1
]}

Pittaway, James F. H. ^{[1
]}

Altieri, Barbara ^{[2
]}

Borges, Kleiton Silva ^{[3
,4
]}

Hadjidemetriou, Irene ^{[1
]}

Ribeiro, Claudio ^{[3
,4
]}

Ruiz-Babot, Gerard ^{[3
,5
]}

Tourigny, David S. ^{[6
]}

Lim, Jiang A. ^{[1
]}

Foster, Julie ^{[7
]}

Cleaver, Julie ^{[7
]}

Sosabowski, Jane ^{[7
]}

Rahman, Nafis ^{[8
]}

Doroszko, Milena ^{[8
]}

Hantel, Constanze ^{[9
,10
]}

Sigala, Sandra ^{[11
]}

Abate, Andrea ^{[11
]}

Tamburello, Mariangela ^{[11
]}

Kiseljak-Vassiliades, Katja ^{[12
,13
]}

Wierman, Margaret ^{[12
,13
]}

Hall, Charlotte ^{[1
]}

Parvanta, Laila ^{[14
]}

Abdel-Aziz, Tarek E. ^{[15
]}

Chung, Teng-Teng ^{[16
]}

Marco, Aimee Di ^{[17
]}

Palazzo, Fausto ^{[17
]}

Gomez-Sanchez, Celso E. ^{[18
,19
]}

Taylor, David R. ^{[20
]}

Rayner, Oliver ^{[20
]}

Ronchi, Cristina L. ^{[21
]}

Gaston-Massuet, Carles ^{[1
]}

Sbiera, Silviu ^{[2
]}

Drake, William M. ^{[1
]}

Rognoni, Emanuel ^{[22
]}

Kroiss, Matthias ^{[2
,23
]}

Breault, David T. ^{[3
,4
]}

Fassnacht, Martin ^{[2
]}

Guasti, Leonardo ^{[1
]}

机构：

[1] Queen Mary Univ London, William Harvey Res Inst, Fac Med & Dent, Ctr Endocrinol, London, England

[2] Univ Wurzburg, Univ Hosp, Dept Med, Div Endocrinol & Diabet, Wurzburg, Germany

[3] Harvard Med Sch, Div Endocrinol, Boston Childrens Hosp, Boston, MA USA

[4] Harvard Stem Cell Inst, Cambridge, MA USA

[5] Tech Univ Dresden, Univ Hosp Carl Gustav Carus, Dept Internal Med 3, Dresden, Germany

[6] Univ Birmingham, Sch Math, Birmingham, England

[7] Queen Mary Univ London, Barts Canc Inst, Barts & London Sch Med & Dent, Ctr Canc Biomarkers & Biotherapeut, Charterhouse Sq, London, England

[8] Univ Turku, Inst Biomed, Turku, Finland

[9] Univ Hosp Zurich USZ, Dept Endocrinol Diabetol & Clin Nutr, Zurich, Switzerland

[10] Univ Zurich UZH, Zurich, Switzerland

[11] Univ Brescia, Dept Mol & Translat Med, Sect Pharmacol, Brescia, Italy

[12] Univ Colorado, Sch Med, Dept Med, Div Endocrinol Metab & Diabet, Aurora, CO USA

[13] Vet Affair Med Ctr, Div Endocrinol Metab & Diabet Rocky Mt Reg, Washington, DC USA

[14] St Bartholomews Hosp, Dept Surg, London, England

[15] Univ Coll London Hosp NHS Fdn Trust, Dept Surg, London, England

[16] Univ Coll London Hosp NHS Fdn Trust, Dept Endocrinol, London, England

[17] Imperial Coll London, Hammersmith Hosp, Dept Endocrine & Thyroid Surg, London, England

[18] Univ Mississippi Med Ctr, GV Sonny Montgomery VA Med Ctr, Endocrine Sect, Jackson, MS USA

[19] Univ Mississippi Med Ctr, Dept Pharmacol & Toxicol, Jackson, MS USA

[20] Kings Coll Hosp London, Dept Clin Biochem Synnovis Analyt, London, England

[21] Univ Birmingham, Inst Metab & Syst Res, Coll Med & Dent Sci, Birmingham, England

[22] Queen Mary Univ London, Blizard Inst, Ctr Cell Biol & Cutaneous Res, Barts & London Sch Med & Dent, London, England

[23] Ludwig Maximilians Univ Munchen, LMU Univ Hosp, Dept Internal Med 4, Munich, Germany

来源：

CANCER COMMUNICATIONS | 2025年

关键词：

D O I：

10.1002/cac2.70012

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页数：6

共 50 条

[1] Adrenocortical stem and progenitor cells: Implications for adrenocortical carcinoma
Simon, Derek P.
Hammer, Gary D.
MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2012, 351 (01) : 2 - 11
[2] Targeting DLK1, a Notch ligand, with an antibody-drug conjugate in adrenocortical carcinoma
Sun, Nai-Yun
Kumar, Suresh
Weiner, Amber
Kim, Yoo Sun
Mendoza, Arnulfo
Nguyen, Rosa
Okada, Reona
Pommier, Yves
Martinez, Dan
Pogoriler, Jennifer
Diskin, Sharon
Maris, John
Del Rivero, Jaydira
Roper, Nitin
CANCER RESEARCH, 2024, 84 (06)
[3] Wnt/βcatenin signaling in adrenocortical stem/progenitor cells: Implications for adrenocortical carcinoma
Kim, A.
Giordano, T. -J.
Kuick, R.
Serecky, K.
Hammer, G. D.
ANNALES D ENDOCRINOLOGIE, 2009, 70 (03) : 156 - 156
[4] DLK1 as a Potential Target against Cancer Stem/Progenitor Cells of Hepatocellular Carcinoma
Xu, Xiao
Liu, Rui-Fang
Zhang, Xin
Huang, Li-Yu
Chen, Fei
Fei, Qian-Lan
Han, Ze-Guang
MOLECULAR CANCER THERAPEUTICS, 2012, 11 (03) : 629 - 638
[5] Dlk1 is a negative regulator of emerging hematopoietic stem and progenitor cells
Mirshekar-Syahkal, Bahar
Haak, Esther
Kimber, Gillian M.
van Leusden, Kevin
Harvey, Kirsty
O'Rourke, John
Laborda, Jorge
Bauer, Steven R.
de Bruijn, Marella F. T. R.
Ferguson-Smith, Anne C.
Dzierzak, Elaine
Ottersbach, Katrin
HAEMATOLOGICA, 2013, 98 (02) : 163 - 171
[6] Adrenocortical cells with stem/progenitor cell properties: Recent advances
Kim, Alex C.
Hammer, Gary D.
MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2007, 265 : 10 - 16
[7] BCL9 Upregulation in Adrenocortical Carcinoma: A Novel Wnt/β-Catenin Activating Event Driving Adrenocortical Malignancy
Brown, Taylor C.
Nicolson, Norman G.
Korah, Reju
Carling, Tobias
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2018, 226 (06) : 988 - 995
[8] Emerging Roles of DLK1 in the Stem Cell Niche and Cancer Stemness
Grassi, Elisa Stellaria
Pietras, Alexander
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY, 2022, 70 (01) : 17 - 28
[9] BCL9 Upregulation in Adrenocortical Carcinoma: A Novel Wnt/β-Catenin Activating Event Driving Adrenocortical Malignancy Invited Commentary
Doherty, Gerard M.
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2018, 226 (06) : 995 - 995
[10] DLK1 Is Associated with Stemness Phenotype in Medullary Thyroid Carcinoma Cell Lines
da Silva, Danilo Dias
Araldi, Rodrigo Pinheiro
Belizario, Mariana Rocha
Rocha, Welbert Gomes
Maciel, Rui Monteiro de Barros
Cerutti, Janete Maria
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (22)

← 1 2 3 4 5 →